<!DOCTYPE html>
<html>
<head>
<meta http-equiv="X-UA-Compatible" content="IE=Edge" />
<meta charset="utf-8" />
</head>

<body style="margin: 0;">

<div id="p95" style="overflow: hidden; position: relative; background-color: white; width: 1210px; height: 935px;">
<style class="shared-css" type="text/css" >
.t {
	transform-origin: bottom left;
	z-index: 2;
	position: absolute;
	white-space: pre;
	overflow: visible;
	line-height: 1.5;
}
.text-container {
	white-space: pre;
}
@supports (-webkit-touch-callout: none) {
	.text-container {
		white-space: normal;
	}
}
</style>
<style type="text/css" >

#t1_95{left:285px;bottom:860px;letter-spacing:-0.32px;word-spacing:0.06px;}
#t2_95{left:285px;bottom:827px;letter-spacing:-0.27px;}
#t3_95{left:36px;bottom:25px;letter-spacing:0.07px;word-spacing:0.01px;}
#t4_95{left:341px;bottom:30px;}
#t5_95{left:348px;bottom:25px;letter-spacing:0.11px;}
#t6_95{left:377px;bottom:30px;}
#t7_95{left:381px;bottom:25px;letter-spacing:0.07px;word-spacing:-0.1px;}
#t8_95{left:540px;bottom:30px;}
#t9_95{left:546px;bottom:25px;letter-spacing:0.07px;}
#ta_95{left:44px;bottom:77px;letter-spacing:0.1px;word-spacing:-0.05px;}
#tb_95{left:44px;bottom:63px;letter-spacing:0.1px;}
#tc_95{left:996px;bottom:873px;letter-spacing:-0.1px;}
#td_95{left:1043px;bottom:853px;letter-spacing:-0.22px;word-spacing:0.13px;}
#te_95{left:1093px;bottom:833px;letter-spacing:-0.09px;}
#tf_95{left:1123px;bottom:47px;letter-spacing:0.32px;}
#tg_95{left:1121px;bottom:28px;letter-spacing:0.19px;word-spacing:-0.15px;}
#th_95{left:36px;bottom:748px;letter-spacing:-0.13px;word-spacing:-0.07px;}
#ti_95{left:36px;bottom:729px;letter-spacing:-0.1px;word-spacing:0.01px;}
#tj_95{left:47px;bottom:711px;letter-spacing:-0.1px;word-spacing:0.01px;}
#tk_95{left:36px;bottom:686px;letter-spacing:-0.09px;}
#tl_95{left:47px;bottom:667px;letter-spacing:-0.09px;}
#tm_95{left:36px;bottom:642px;letter-spacing:-0.1px;word-spacing:0.01px;}
#tn_95{left:47px;bottom:624px;letter-spacing:-0.09px;}
#to_95{left:47px;bottom:605px;letter-spacing:-0.09px;}
#tp_95{left:36px;bottom:580px;}
#tq_95{left:47px;bottom:580px;letter-spacing:-0.1px;}
#tr_95{left:47px;bottom:562px;letter-spacing:-0.12px;word-spacing:0.03px;}
#ts_95{left:321px;bottom:569px;letter-spacing:-0.12px;}
#tt_95{left:42px;bottom:544px;}
#tu_95{left:59px;bottom:544px;letter-spacing:-0.09px;}
#tv_95{left:58px;bottom:525px;letter-spacing:-0.09px;}
#tw_95{left:42px;bottom:507px;}
#tx_95{left:59px;bottom:507px;letter-spacing:-0.1px;word-spacing:0.01px;}
#ty_95{left:861px;bottom:514px;letter-spacing:-0.12px;}
#tz_95{left:884px;bottom:507px;letter-spacing:-0.11px;word-spacing:0.02px;}
#t10_95{left:58px;bottom:489px;letter-spacing:-0.09px;}
#t11_95{left:42px;bottom:470px;}
#t12_95{left:59px;bottom:470px;letter-spacing:-0.1px;word-spacing:-0.03px;}
#t13_95{left:58px;bottom:452px;letter-spacing:-0.1px;}
#t14_95{left:58px;bottom:434px;letter-spacing:-0.09px;}
#t15_95{left:892px;bottom:441px;}
#t16_95{left:36px;bottom:408px;}
#t17_95{left:47px;bottom:408px;letter-spacing:-0.1px;word-spacing:0.01px;}
#t18_95{left:47px;bottom:390px;letter-spacing:-0.09px;}
#t19_95{left:47px;bottom:372px;letter-spacing:-0.09px;}
#t1a_95{left:496px;bottom:778px;letter-spacing:0.44px;word-spacing:-0.26px;}
#t1b_95{left:36px;bottom:198px;}
#t1c_95{left:46px;bottom:192px;letter-spacing:0.1px;word-spacing:0.03px;}
#t1d_95{left:45px;bottom:176px;letter-spacing:0.14px;}
#t1e_95{left:36px;bottom:165px;}
#t1f_95{left:46px;bottom:159px;letter-spacing:0.13px;word-spacing:-0.01px;}
#t1g_95{left:36px;bottom:148px;}
#t1h_95{left:46px;bottom:142px;letter-spacing:0.12px;word-spacing:0.02px;}
#t1i_95{left:36px;bottom:131px;}
#t1j_95{left:46px;bottom:125px;letter-spacing:0.1px;word-spacing:0.02px;}
#t1k_95{left:45px;bottom:108px;letter-spacing:0.14px;}
#t1l_95{left:1091px;bottom:268px;letter-spacing:-0.11px;}
#t1m_95{left:23px;bottom:915px;letter-spacing:-0.14px;}

.s0_95{font-size:28px;font-family:Arial-BoldMT_5te;color:#000;}
.s1_95{font-size:9px;font-family:ArialMT_5tg;color:#000;}
.s2_95{font-size:5px;font-family:ArialMT_5tg;color:#000;}
.s3_95{font-size:12px;font-family:Arial-BoldMT_5te;color:#000;}
.s4_95{font-size:17px;font-family:ArialMT_5tg;color:#0065A4;}
.s5_95{font-size:17px;font-family:Arial-BoldMT_5te;color:#000;}
.s6_95{font-size:17px;font-family:Arial-BoldMT_jz;color:#000;}
.s7_95{font-size:14px;font-family:Arial-BoldMT_5te;color:#000;}
.s8_95{font-size:17px;font-family:Webdings_k6;color:#000;}
.s9_95{font-size:12px;font-family:ArialMT_5tg;color:#000;}
.sa_95{font-size:15px;font-family:ArialMT_5tg;color:#000;}
.sb_95{font-size:17px;font-family:Arial-BoldMT_5te;color:#0065A4;}
.sc_95{font-size:11px;font-family:Helvetica, Arial, sans-serif;color:#000;}
</style>
<style id="fonts95" type="text/css" >

@font-face {
	font-family: Arial-BoldMT_5te;
	src: url("fonts/Arial-BoldMT_5te.woff") format("woff");
}

@font-face {
	font-family: Arial-BoldMT_jz;
	src: url("fonts/Arial-BoldMT_jz.woff") format("woff");
}

@font-face {
	font-family: ArialMT_5tg;
	src: url("fonts/ArialMT_5tg.woff") format("woff");
}

@font-face {
	font-family: Webdings_k6;
	src: url("fonts/Webdings_k6.woff") format("woff");
}

</style>
<div id="pg95Overlay" style="width:100%; height:100%; position:absolute; z-index:1; background-color:rgba(0,0,0,0); -webkit-user-select: none;"></div>
<div id="pg95" style="-webkit-user-select: none;"><object width="1210" height="935" data="95/95.svg" type="image/svg+xml" id="pdf95" style="width:1210px; height:935px; z-index: 0;"></object></div>
<div class="text-container"><span id="t1_95" class="t s0_95">NCCN Guidelines Version 4.2024 </span>
<span id="t2_95" class="t s0_95">Head and Neck Cancers </span>
<span id="t3_95" class="t s1_95">Version 4.2024, 5/1/2024 © 2024 National Comprehensive Cancer Network </span>
<span id="t4_95" class="t s2_95">® </span>
<span id="t5_95" class="t s1_95">(NCCN </span>
<span id="t6_95" class="t s2_95">® </span>
<span id="t7_95" class="t s1_95">), All rights reserved. NCCN Guidelines </span>
<span id="t8_95" class="t s2_95">® </span>
<span id="t9_95" class="t s1_95">and this illustration may not be reproduced in any form without the express written permission of NCCN. </span>
<span id="ta_95" class="t s3_95">Note: All recommendations are category 2A unless otherwise indicated. </span>
<span id="tb_95" class="t s3_95">Clinical Trials: NCCN believes that the best management of any patient with cancer is in a clinical trial. Participation in clinical trials is especially encouraged. </span>
<span id="tc_95" class="t s4_95">NCCN Guidelines Index </span>
<span id="td_95" class="t s4_95">Table of Contents </span>
<span id="te_95" class="t s4_95">Discussion </span>
<span id="tf_95" class="t s5_95">IMG-A </span>
<span id="tg_95" class="t s5_95">3 OF 4 </span>
<span id="th_95" class="t s5_95">Locoregionally Advanced Disease: &lt;6 Months Post-Treatment (Short-Term) </span>
<span id="ti_95" class="t s5_95">• Following surgery in patients with locoregionally advanced cancer, short-term post-treatment imaging is recommended for those who show </span>
<span id="tj_95" class="t s5_95">signs of early recurrence or who are at high risk of early recurrence prior to starting adjuvant postoperative therapy. </span>
<span id="tk_95" class="t s5_95">• Obtain CT and/or MRI within 3–4 months after surgical treatment for patients with locoregionally advanced disease or with altered anatomy </span>
<span id="tl_95" class="t s5_95">causing challenging physical exam assessment, in order to establish a new baseline for future comparisons. </span>
<span id="tm_95" class="t s5_95">• In cases of concern for incomplete response, a CT or MRI scan may be obtained much earlier, such as 4–8 weeks post-treatment or even </span>
<span id="tn_95" class="t s6_95" data-mappings='[[30,"fi"]]'>immediately based on the speciﬁc clinical situation. US of the neck for targeted sampling of any suspicious tissues may also be helpful, but </span>
<span id="to_95" class="t s6_95" data-mappings='[[58,"fi"]]'>results can be variably interpreted depending on the speciﬁc clinical situation. </span>
<span id="tp_95" class="t s5_95">• </span><span id="tq_95" class="t s6_95" data-mappings='[[54,"fi"]]'>FDG-PET/CT should be performed within 3–6 months of deﬁnitive radiation or systemic therapy/RT for assessment of treatment response </span>
<span id="tr_95" class="t s5_95">and to identify any residual tumor. </span>
<span id="ts_95" class="t s7_95">3-6 </span>
<span id="tt_95" class="t s8_95"></span><span id="tu_95" class="t s6_95" data-mappings='[[64,"fi"]]'>Early FDG-PET/CT scans before 12 weeks are associated with signiﬁcant false-positive rates and should be avoided in the absence of </span>
<span id="tv_95" class="t s5_95">signs of recurrence or progression. </span>
<span id="tw_95" class="t s8_95"></span><span id="tx_95" class="t s5_95">The optimal timing of PET scans after radiation treatment appears to be at the 3- to 6-month window. </span>
<span id="ty_95" class="t s7_95">3,4 </span>
<span id="tz_95" class="t s5_95">A negative PET at this time point </span>
<span id="t10_95" class="t s5_95">predicts improved overall survival at 2 years. </span>
<span id="t11_95" class="t s8_95"></span><span id="t12_95" class="t s6_95" data-mappings='[[24,"fi"]]'>In patients receiving deﬁnitive RT-based treatment of mucosal squamous cell carcinoma with AJCC 7th edition N2–N3 nodal disease, FDG- </span>
<span id="t13_95" class="t s5_95">PET/CT surveillance approach led to fewer neck dissections and considerable cost savings compared to a routine approach of planned </span>
<span id="t14_95" class="t s5_95">post-treatment neck dissection. The majority of cases studied were p16-positive oropharyngeal cancers. </span>
<span id="t15_95" class="t s7_95">5 </span>
<span id="t16_95" class="t s5_95">• </span><span id="t17_95" class="t s6_95" data-mappings='[[115,"fi"]]'>In the special case of patients who are treated initially with induction chemotherapy prior to the initiation of deﬁnitive therapy, either CT or </span>
<span id="t18_95" class="t s6_95">MRI has typically been obtained after 2–3 cycles of induction. Chest CT and/or FDG-PET/CT (with diagnostic-quality imaging of the regions </span>
<span id="t19_95" class="t s5_95">of the body at risk) may be obtained if there is concern for locoregional or distant metastatic progression. </span>
<span id="t1a_95" class="t s5_95">PRINCIPLES OF IMAGING </span>
<span id="t1b_95" class="t s9_95">3 </span>
<span id="t1c_95" class="t sa_95">Cheung PK, Chin RY, Eslick GD. Detecting residual/recurrent head neck squamous cell carcinomas using PET or PET/CT: Systematic review and meta-analysis. </span>
<span id="t1d_95" class="t sa_95">Otolaryngol Head Neck Surg 2016;154:421-432. </span>
<span id="t1e_95" class="t s9_95">4 </span>
<span id="t1f_95" class="t sa_95">Heineman TE, Kuan EC, St John MA. When should surveillance imaging be performed after treatment for head and neck cancer? Laryngoscope 2017;127:533-534. </span>
<span id="t1g_95" class="t s9_95">5 </span>
<span id="t1h_95" class="t sa_95">Mehanna H, Wong WL, McConkey CC, et al. PET-CT surveillance versus neck dissection in advanced head and neck cancer. N Engl J Med 2016;374:1444-1454. </span>
<span id="t1i_95" class="t s9_95">6 </span>
<span id="t1j_95" class="t sa_95">Ng SP, Pollard C, 3rd, Berends J, et al. Usefulness of surveillance imaging in patients with head and neck cancer who are treated with definitive radiotherapy. Cancer </span>
<span id="t1k_95" class="t sa_95">2019;125:1823-1829. </span>
<span id="t1l_95" class="t sb_95">Continued </span>
<span id="t1m_95" class="t sc_95">Printed by Fredd Merc on 8/29/2024 4:45:54 AM. For personal use only. Not approved for distribution. Copyright © 2024 National Comprehensive Cancer Network, Inc., All Rights Reserved. </span></div>

</div>
</body>
</html>
